Open-uri20151222-3-nmoh9y_thumb

Asher Mullard

Science Journalist

Asher Mullard

Writing about drugs, biotech, the pharmaceutical industry, health and more.

Featured

Open-uri20171006-4-uny10_profile

The drug-maker's guide to the galaxy

Machine learning is helping chemists search the vast chemical universe for better medicines.
Nature Link to Story
Open-uri20161221-4-354q7o_profile

Immunotherapies move beyond cancer, with first foray into sepsis

Could cutting-edge cancer drugs beat back deadly infections of the blood?
Boston Globe/STAT Link to Story
Open-uri20160129-3-xra5cy_profile

Anti-inflammatory gets long awaited test as an antidepressant

J&J is testing a radical new approach to depression — by dialing down inflammation in the body.
Boston Globe/STAT Link to Story
Open-uri20151117-3-a77v2w_profile

Run, forest, run

How to move a forest (before climate change kills it).
The Walrus Link to Story
_tmp_articling-import-20090513084911576656_459159a-i2.0_profile

Tinker, bacteria, eukaryote, spy

Bacteria and their hosts spy on one another, intercepting chemical communications.
Nature Link to Story
Fatbusters_profile

Fat busters: Are diet pills an impossible dream?

The next generation of weight-loss drugs is on its way. Will their side effects be hard to swallow?
New Scientist Link to Story
453578a-i2.0_profile

The inside story

The human body teems with microbes. Now global efforts are cataloguing this vast 'microbiome'.
Nature Link to Story
Open-uri20151020-3-12dj4ct_profile

Use of personalized cancer drugs runs ahead of the science

Trial finds no benefit in speculative prescriptions of genetic tailored cancer treatments.
Nature Link to Story
Open-uri20140209-2-ts0e3j_profile

Multicompany trials adapt to disciplines beyond cancer

Researchers are catching on to the benefits of adaptive, collaborative clinical trials.
Nature Medicine Link to Story
Nrd3545-i1_profile

Reliability of ‘new drug target’ claims called into question

Nearly two-thirds of academic biomedical research cannot be replicated in industry labs.
Nature Reviews Drug Discovery Link to Story
Open-uri20150313-3-bu5878_profile

Still Alice film review

Still Alice, a raw and rare film about what it's like to have Alzheimer's disease.
The Lancet Link to Story
Open-uri20140221-2-wrj2wd_profile

Dallas Buyers Club film review

Dallas Buyers Club flirts with a laissez-faire approach to drug development and drug access.
The Lancet Link to Story

About

Asher Mullard

I am a journalist, covering the science and business of biological discoveries and emerging drugs. I have written for Nature, The Lancet, The Boston Globe, The New Scientist, The Walrus and many others.

My article 'Run, Forest, Run' received Honorary Mention in the National Magazine Awards.

I am a contributing editor for Nature Reviews Drug Discovery.

Please email me at ashermullard@gmail.com.